Published in BMJ on May 11, 1991
Towards safer endoscopic retrograde cholangiopancreatography. Gut (1993) 1.30
Treating delayed endoscopic sphincterotomy-induced bleeding: epinephrine injection with or without thermotherapy. World J Gastroenterol (2009) 1.04
Predictors of re-bleeding after endoscopic hemostasis for delayed post-endoscopic sphincterotomy bleeding. World J Gastroenterol (2016) 0.75
Late bleeding after endoscopic sphincterotomy for bile duct calculi. BMJ (1991) 0.75
Endoscopic sphincterotomy in 1000 consecutive patients. Lancet (1989) 3.20
Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg (1985) 2.66
Bleeding after endoscopic sphincterotomy. Ann R Coll Surg Engl (1985) 1.14
Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04
ERCP training--time for change. Gut (2000) 1.72
Treatment of radiation proctitis. Clin Oncol (R Coll Radiol) (2007) 1.64
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Palliative laser therapy for malignant dysphagia. Gut (1987) 1.56
A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol (2001) 1.54
Injection sclerotherapy for oesophageal varices in the elderly. Age Ageing (1983) 1.48
Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. Aliment Pharmacol Ther (2008) 1.46
Alcohol abuse and the burden on the NHS--time for action. J R Coll Physicians Lond (2000) 1.44
The burden of alcohol misuse on an inner-city general hospital. QJM (2000) 1.31
Gastrointestinal manifestations of Addison's disease. Am J Gastroenterol (1989) 1.26
Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases. Aliment Pharmacol Ther (1997) 1.22
Alcohol enhances vitamin C excretion in the urine. Alcohol Alcohol (1986) 1.18
A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol (1992) 1.15
A national training programme for gastroenterology and hepatology. Gut (1996) 1.14
Laser irradiation of inoperable tumours of the colon and rectum. Br Med J (Clin Res Ed) (1985) 1.13
Influence of isoproterenol and propranolol on human intestinal transport in vivo. Gastroenterology (1981) 1.12
A snapshot of colonoscopy practice in England: stimulus for improvement. Gut (2004) 1.08
Open label trial of oral clarithromycin in active Crohn's disease. Aliment Pharmacol Ther (2000) 1.08
Transjugular liver biopsy. Br Med J (1977) 1.07
Paracetamol-induced acute pancreatitis. Br Med J (1977) 1.07
Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther (1990) 1.05
Experience with transjugular liver biopsy. Gut (1983) 1.04
Plugged liver biopsy in patients with impaired coagulation. Dig Dis Sci (1989) 1.04
New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer (1999) 1.03
The influence of a parasympathetic agonist and antagonist on human intestinal transport in vivo. Gastroenterology (1980) 1.00
Are HLA antigens important in the development of alcohol-induced liver disease? Br Med J (Clin Res Ed) (1982) 0.99
Ultrasound diagnosis of bile duct calculi. Br Med J (Clin Res Ed) (1986) 0.97
The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women. Xenobiotica (1983) 0.97
TIPSS in the treatment of ectopic variceal bleeding. Hepatogastroenterology (2006) 0.96
Addison's disease presenting as anorexia nervosa in a young man. Postgrad Med J (1988) 0.96
Computed tomographic scanning in liver disease. Clin Radiol (1978) 0.96
Orocaecal transit time in health and in thyroid disease. Gut (1989) 0.95
Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571. Aliment Pharmacol Ther (1997) 0.95
Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics (1995) 0.91
Half-life time or clearance of indocyanine green in patients with liver disease. Hepatogastroenterology (1982) 0.90
Intracellular electrolyte depletion in patients with ileostomies. Gut (1978) 0.89
Biphasic synovial sarcoma in the small intestinal mesentery. Cancer (1995) 0.88
Cholecystokinin cholecystography, sonography, and scintigraphy: detection of chronic acalculous cholecystitis. AJR Am J Roentgenol (1982) 0.88
Surreptitious laxative abuse. Gastroenterology (1979) 0.88
Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease. Gut (1980) 0.88
Screening for occult gastrointestinal bleeding in hospital patients. J R Soc Med (1981) 0.88
Recent developments in the management of Peutz-Jeghers syndrome in childhood. Eur J Pediatr Surg (1997) 0.88
Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise. Thorax (1984) 0.87
Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease. Gut (1978) 0.87
Combined surgical and endoscopic clearance of small-bowel polyps in Peutz-Jeghers syndrome. J R Soc Med (2003) 0.87
Crohn's disease and myasthenia gravis: a possible role for thymectomy. Gut (1994) 0.86
Non-psychogenic primary polydipsia in autoimmune chronic active hepatitis with severe hyperglobulinaemia. Gut (1988) 0.86
Comparison between the cellobiose/mannitol and 51Cr-labelled ethylenediaminetetra-acetate absorption tests in the detection of coeliac disease. Clin Sci (Lond) (1988) 0.86
Colonic involvement in Fabry's disease. Postgrad Med J (1991) 0.86
Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res (1997) 0.85
Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation. Gastroenterology (1980) 0.84
Pregnancy in Crigler-Najjar syndrome. Case report. Br J Obstet Gynaecol (1991) 0.84
Improved method of transvenous liver biopsy. Br Med J (1978) 0.84
Comparison of the Trucut and Surecut liver biopsy needles. J Clin Pathol (1982) 0.84
Measurement of menadione-mediated DNA damage in human lymphocytes using the comet assay. Free Radic Res (1997) 0.83
Bell's Palsy associated with hypothyroidism. Br J Clin Pract (1985) 0.83
HCV-associated liver cancer. Lancet (1995) 0.83
Infective endocarditis due to Yersinia enterocolitica. J Infect (1983) 0.82
Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA). J Med Virol (1998) 0.82
Reduction in toxicity of doxorubicin by liposomal entrapment. Lancet (1987) 0.82
Yersinia pseudotuberculosis ileitis presenting with severe intestinal haemorrhage. J R Soc Med (1988) 0.81
Oesophageal self-bougienage. Lancet (1982) 0.80
Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am J Gastroenterol (1998) 0.80
Anterior lesser curve seromyotomy and posterior truncal vagotomy versus truncal vagotomy and pyloroplasty in the treatment of chronic duodenal ulcer. Br J Surg (1990) 0.80
Development of the bile acid pool in rats from neonatal life through puberty to maturity. Digestion (1983) 0.79
Recent developments in the treatment of alcoholic hepatitis. QJM (2003) 0.79
Computed tomography: qualitative and quantitative recognition of liver disease in haemophilia. J Comput Assist Tomogr (1983) 0.78
Achalasia in Anderson-Fabry's disease. J R Soc Med (1984) 0.77
General practice nurses' knowledge of alcohol use and misuse: a questionnaire survey. Alcohol Alcohol (2000) 0.77
Review article: controversy in the therapy of gastro-oesophageal reflux disease--long-term proton pump inhibition or laparoscopic anti-reflux surgery? Aliment Pharmacol Ther (1997) 0.77
Enteroscopy. Curr Opin Gastroenterol (2000) 0.77
Clustering of hepatitis B virus infection and hepatocellular carcinoma in a family. J R Soc Med (1981) 0.77
Evaluation of two simplified methods for genotyping hepatitis C virus. J Med Virol (1997) 0.77
Hepatitis G virus RNA and its relation to hepatitis C infection in adult haemophilic patients. Br J Haematol (1997) 0.77
Splitting of the polyethylene coverings as a previously unrecognized complication of oesophageal metallic covered stent (Gianturco-Rösch) inserted for malignant stricture. Endoscopy (1998) 0.77
Effects of niacin on biliary lipid output in the rat. Biochem Pharmacol (1993) 0.76
A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy. Anticancer Drugs (1992) 0.76
The effect of chronic ethanol intake on leucine absorption from the rat small intestine. Alcohol Alcohol (1989) 0.76
Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver. J Nucl Med (1991) 0.76
A comparison of two methods of whole gut lavage for colonoscopy. Br J Surg (1981) 0.76
The effects of gastrin and peptide analogues related to gastrin on cats. J Physiol (1968) 0.76
Heliox treatment for pneumatosis cystoides coli. Lancet (1995) 0.75
Controlled trial of cyclophosphamide in active chronic hepatitis. Br Med J (1979) 0.75
Bone disease after jejuno-ileal bypass for morbid obesity. Postgrad Med J (1983) 0.75
Use of somatostatin in the management of pancreatic haemobilia. Postgrad Med J (1989) 0.75
Liver biopsy in the diagnosis of malignancy. QJM (1995) 0.75
Obscure anaemia and hepatic dysfunction in Castleman's disease. Gut (1991) 0.75
Treatment of oesophago-gastric tumours. Endoscopy (2002) 0.75
Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration? Br Med J (Clin Res Ed) (1984) 0.75
Study of ion transport across biopsies of ileostomy in vitro: search for evidence of intestinal 'adaptation' after colectomy. Gut (1980) 0.75